RhumbLine Advisers’s Connect Biopharma Holdings CNTB Stock Holding History
Bought
Maintained
Sold
Other funds holding CNTB
BCM
DMKJ
RhumbLine Advisers's CNTB Position: Q3 2026 in Review
RhumbLine Advisers increased its Connect Biopharma Holdings (CNTB) stake by 44% in Q3 2026, buying an estimated $9.8K and bringing the position to 15,790 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3765.
RhumbLine Advisers first reported a position in CNTB in Q2 2023 and has held it in 14 quarters since. The position peaked at $28.7K in Q1 2024. 64 funds tracked by Wall St. Rank hold CNTB as of Q3 2026.
- RhumbLine Advisers held 15,790 shares of Connect Biopharma Holdings worth $17.4K as of Q3 2026.
- RhumbLine Advisers bought 4,811 Connect Biopharma Holdings shares in Q3 2026, an estimated $9.8K.
- Connect Biopharma Holdings made up ﹤0.01% of RhumbLine Advisers's portfolio in Q3 2026, its #3765 holding.
- RhumbLine Advisers first reported a position in Connect Biopharma Holdings in Q2 2023 and has held it in 14 quarters since.
- RhumbLine Advisers's Connect Biopharma Holdings position peaked at $28.7K in Q1 2024.
- 64 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2026.
Based on RhumbLine Advisers's 13F filing for Q3 2026, filed 10 Nov 2026.